Bei Akademie registrieren
Galderma, CH1335392721

Galderma stock: AGM approves dividend and board changes

Published on 11/09/2026 at 17:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Galderma stock reflects the shareholder-approved dividend and refreshed board composition. The 2025 reporting package also received approval.

Shareholder decisions and governance

  • Galderma shareholders approved a gross dividend of CHF 0.35 per dividend-bearing share at the April 22 annual meeting.
  • Harry Kirsch joined the board as an independent director, while two L'Oreal representatives became non-independent members.
  • The meeting also approved Galderma's 2025 financial, non-financial and compensation reports.
Galderma, CH1335392721, Illustration mit AI erstellt.
Galderma, CH1335392721, Illustration mit AI erstellt.

Galderma shareholders approved the board's proposals at the Annual General Meeting in Zug on April 22, 2026. The decision included a gross dividend of CHF 0.35 per dividend-bearing share and changes to the board.

Since our relevant report on November 5, the Lang & Schwarz quote moved from 213.30 euros at 18:05 CET to 207.50 euros at 17:09 CET on Monday, November 9, a decline of 2.72 percent. Galderma stock traded at 207.50 euros on Lang & Schwarz at 17:09 CET on Monday, November 9, 2026.

Dividend and board decisions

According to Galderma's AGM release, shareholders approved the distribution from reserves from capital contributions. The release said the payment would be made under the applicable Swiss tax rules.

Harry Kirsch was elected as an independent board member. Samuel du Retail and Delphine Viguier-Hovasse, both L'Oreal representatives, were elected as non-independent members. Thomas Ebeling, Daniel Browne, Maria Teresa Hilado, Karen Lee Ling, Roberto Marques, Sherilyn McCoy and Flemming Ornskov were re-elected.

Reporting approval adds continuity

Shareholders also approved Galderma's 2025 Annual Financial Statements, Non-Financial Report and Compensation Report. The company said detailed voting results and the official minutes would be published on its investor relations website within two weeks of the meeting.

Galderma Group AG

  • ISIN: CH1335392721
  • Annual meeting: April 22, 2026, in Zug
  • Approved dividend: CHF 0.35 gross per dividend-bearing share
  • Lang & Schwarz quote: 207.50 euros at 17:09 CET on November 9, 2026

Swiss market developments are covered in our current market reports.

More news and analyses on Galderma stock are available here.

Disclaimer...
en | CH1335392721 | GALDERMA | boerse | 70482202 | bgmi